Doximity, Inc.(DOCS)Stock Performance & ReturnsNYSE
Returns, drawdowns and benchmark comparison
Peer Comparison
Relative scale, growth, and profitability vs sector peers
| Ticker | Market Cap | P/E Ratio | Revenue Growth | Net Margin | EPS | ROE | Debt/Equity | Dividend Yield | 52W High | 52W Low |
|---|---|---|---|---|---|---|---|---|---|---|
DOCS | 5.94 B | 39.24x | 7.30% | 25.48% | $0.85 | 17.21% | 0.01x | 0.00% | $71.37 | $17.15 |
VEEV | 51.60 B | 52.24x | 17.60% | 29.35% | $6.10 | 14.43% | 0.02x | 0.00% | $319.95 | $148.05 |
WAY | 5.52 B | 41.16x | 18.10% | 11.18% | $0.70 | 3.77% | 0.37x | 0.00% | $40.35 | $17.26 |
HTFL | 4.83 B | - | 47.60% | -55.82% | -$0.24 | -154.23% | 0.10x | 0.00% | $54.32 | $20.13 |
SDGR | 1.54 B | - | 7.50% | -20.98% | -$0.74 | -16.17% | 0.33x | 0.00% | $33.78 | $10.94 |
Peer Valuation & Performance Analysis
Peer group analysis for Doximity, Inc. (DOCS) compared to its primary competitors (including VEEV, WAY, HTFL) reveals distinct metrics. DOCS trades at a valuation premium compared to its competitors, with a P/E ratio of 39.2x versus the peer average of -42.5x (representing a -192% premium). This indicates that the market expects superior growth or commands a quality premium for DOCS. In terms of growth, DOCS's revenue growth of 7.3% lags behind the peer average of 22.7%, indicating potential market share losses or slower industry adoption. Additionally, it boasts superior profitability with a net margin of 25.5% compared to the peer average of -9.1%, demonstrating strong cost controls and pricing power.
Peer Performance Rankings
Ranking comparison across key performance metrics
P/E Ratio (Lower is Better)
Revenue Growth
Net Profit Margin
Financial Rankings Summary
• DOCS ranks #1 in P/E ratio, #5 in revenue growth, and #2 in profit margins
• Average ranking: #3 - 📊 Solid financials relative to peer group
• Rankings based on actual financial data from company reports
Historical Trading Data
Price and volume data with customizable timeframes
Showing 15 of 15 trading sessions from the last 15 days
| Date | Open | High | Low | Close | Volume | Daily Change |
|---|---|---|---|---|---|---|
| 2026-10-21 | $33.04 | $34.26 | $33.11 | $33.58 | 2,899,320 | +0.69% |
| 2026-10-20 | $31.96 | $34.10 | $31.82 | $33.35 | 4,356,000 | +6.04% |
| 2026-10-19 | $30.80 | $31.57 | $30.59 | $31.45 | 2,026,200 | +1.55% |
| 2026-10-16 | $31.97 | $32.11 | $30.59 | $30.97 | 3,582,700 | -1.68% |
| 2026-10-15 | $29.75 | $31.54 | $29.62 | $31.50 | 3,132,700 | +5.28% |
| 2026-10-14 | $31.13 | $31.13 | $29.68 | $29.92 | 2,693,300 | -2.06% |
| 2026-10-13 | $30.68 | $31.21 | $30.35 | $30.55 | 2,961,600 | -0.10% |
| 2026-10-12 | $30.64 | $30.92 | $30.20 | $30.58 | 3,392,800 | +0.26% |
| 2026-10-09 | $29.45 | $30.50 | $29.16 | $30.50 | 4,941,500 | +3.81% |
| 2026-10-08 | $27.72 | $29.49 | $27.72 | $29.38 | 5,196,300 | +6.10% |
| 2026-10-07 | $27.62 | $28.28 | $27.52 | $27.69 | 2,389,100 | -0.36% |
| 2026-10-06 | $29.06 | $29.20 | $27.71 | $27.79 | 2,309,800 | -2.76% |
| 2026-10-05 | $28.01 | $28.90 | $28.01 | $28.58 | 3,164,000 | +2.33% |
| 2026-10-02 | $28.93 | $29.20 | $27.80 | $27.93 | 2,672,100 | -2.00% |
| 2026-10-01 | $28.91 | $28.95 | $28.07 | $28.50 | 3,340,600 | +0.56% |
Explore More Analysis for DOCS
Additional research, tools, and technical breakdowns
Stock Analyzer Report
Deep-dive automated research and stock rating report.
DCF Fair Value Calculator
Discounted cash flow model and intrinsic value projection.
AI Price Predictions
Multi-scenario price predictions and consensus targets.
Insider Activity Tracker
Track buying/selling behavior of corporate insiders.
Earnings Calendar
Track upcoming and historical corporate earnings reports.
Market Insights & Research
Read the latest analysis articles and expert research.